520 related articles for article (PubMed ID: 18455265)
21. Novel assay with fluorescence-labelled PrP peptides for differentiating L-type atypical and classical BSEs, and scrapie.
Kasai K; Hirata A; Ohyama T; Nokihara K; Yokoyama T; Mohri S
FEBS Lett; 2012 Feb; 586(4):325-9. PubMed ID: 22285492
[TBL] [Abstract][Full Text] [Related]
22. NMR solution structure and SRP54M predicted interaction of the N-terminal sequence (1-30) of the ovine Doppel protein.
Pimenta J; Viegas A; Sardinha J; Martins IC; Cabrita EJ; Fontes CM; Prates JA; Pereira RM
Peptides; 2013 Nov; 49():32-40. PubMed ID: 23973967
[TBL] [Abstract][Full Text] [Related]
23. Structural differences between allelic variants of the ovine prion protein revealed by molecular dynamics simulations.
Bujdoso R; Burke DF; Thackray AM
Proteins; 2005 Dec; 61(4):840-9. PubMed ID: 16252284
[TBL] [Abstract][Full Text] [Related]
24. Molecular modelling indicates that the pathological conformations of prion proteins might be beta-helical.
Downing DT; Lazo ND
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):453-60. PubMed ID: 10510313
[TBL] [Abstract][Full Text] [Related]
25. Control of the pathogenic conformational change of the prion protein by an attractor of low order.
Havsteen BH
J Theor Biol; 2004 Nov; 231(1):39-48. PubMed ID: 15363928
[TBL] [Abstract][Full Text] [Related]
26. A role for His155 in binding of human prion peptide144-167 to immobilised prion protein.
Hesp JR; Raven ND; Sutton JM
Biochem Biophys Res Commun; 2007 Oct; 362(3):695-9. PubMed ID: 17761148
[TBL] [Abstract][Full Text] [Related]
27. Morphology and secondary structure of stable beta-oligomers formed by amyloid peptide PrP(106-126).
Walsh P; Yau J; Simonetti K; Sharpe S
Biochemistry; 2009 Jun; 48(25):5779-81. PubMed ID: 19476383
[TBL] [Abstract][Full Text] [Related]
28. Beta-hairpin conformation of fibrillogenic peptides: structure and alpha-beta transition mechanism revealed by molecular dynamics simulations.
Daidone I; Simona F; Roccatano D; Broglia RA; Tiana G; Colombo G; Di Nola A
Proteins; 2004 Oct; 57(1):198-204. PubMed ID: 15326604
[TBL] [Abstract][Full Text] [Related]
29. Spectroscopic characterization of conformational differences between PrPC and PrPSc: an alpha-helix to beta-sheet transition.
Baldwin MA; Pan KM; Nguyen J; Huang Z; Groth D; Serban A; Gasset M; Mehlhorn I; Fletterick RJ; Cohen FE
Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):435-41. PubMed ID: 7913763
[TBL] [Abstract][Full Text] [Related]
30. Spontaneous beta-helical fold in prion protein: the case of PrP(82-146).
Saracino GA; Villa A; Moro G; Cosentino U; Salmona M
Proteins; 2009 Jun; 75(4):964-76. PubMed ID: 19089953
[TBL] [Abstract][Full Text] [Related]
31. Toward the molecular basis of inherited prion diseases: NMR structure of the human prion protein with V210I mutation.
Biljan I; Ilc G; Giachin G; Raspadori A; Zhukov I; Plavec J; Legname G
J Mol Biol; 2011 Sep; 412(4):660-73. PubMed ID: 21839748
[TBL] [Abstract][Full Text] [Related]
32. Structural characterization of a neurotoxic threonine-rich peptide corresponding to the human prion protein alpha 2-helical 180-195 segment, and comparison with full-length alpha 2-helix-derived peptides.
Ronga L; Palladino P; Saviano G; Tancredi T; Benedetti E; Ragone R; Rossi F
J Pept Sci; 2008 Oct; 14(10):1096-102. PubMed ID: 18563793
[TBL] [Abstract][Full Text] [Related]
33. NMR solution structure and membrane interaction of the N-terminal sequence (1-30) of the bovine prion protein.
Biverståhl H; Andersson A; Gräslund A; Mäler L
Biochemistry; 2004 Nov; 43(47):14940-7. PubMed ID: 15554701
[TBL] [Abstract][Full Text] [Related]
34. The emerging principles of mammalian prion propagation and transmissibility barriers: Insight from studies in vitro.
Surewicz WK; Jones EM; Apetri AC
Acc Chem Res; 2006 Sep; 39(9):654-62. PubMed ID: 16981682
[TBL] [Abstract][Full Text] [Related]
35. Spontaneous deamidation and isomerization of Asn108 in prion peptide 106-126 and in full-length prion protein.
Sandmeier E; Hunziker P; Kunz B; Sack R; Christen P
Biochem Biophys Res Commun; 1999 Aug; 261(3):578-83. PubMed ID: 10441469
[TBL] [Abstract][Full Text] [Related]
36. Peptide NMHRYPNQ of the cellular prion protein (PrP(C)) inhibits aggregation and is a potential key for understanding prion-prion interactions.
Rehders D; Claasen B; Redecke L; Buschke A; Reibe C; Jehmlich N; von Bergen M; Betzel C; Meyer B
J Mol Biol; 2009 Sep; 392(1):198-207. PubMed ID: 19607841
[TBL] [Abstract][Full Text] [Related]
37. NMR solution structure of the peptide fragment 1-30, derived from unprocessed mouse Doppel protein, in DHPC micelles.
Papadopoulos E; Oglecka K; Mäler L; Jarvet J; Wright PE; Dyson HJ; Gräslund A
Biochemistry; 2006 Jan; 45(1):159-66. PubMed ID: 16388591
[TBL] [Abstract][Full Text] [Related]
38. Local interactions drive the formation of nonnative structure in the denatured state of human alpha-lactalbumin: a high resolution structural characterization of a peptide model in aqueous solution.
Demarest SJ; Hua Y; Raleigh DP
Biochemistry; 1999 Jun; 38(22):7380-7. PubMed ID: 10353850
[TBL] [Abstract][Full Text] [Related]
39. Amino acid determinants of beta-hairpin conformation in erythropoeitin receptor agonist peptides derived from a phage display library.
Skelton NJ; Russell S; de Sauvage F; Cochran AG
J Mol Biol; 2002 Mar; 316(5):1111-25. PubMed ID: 11884148
[TBL] [Abstract][Full Text] [Related]
40. The role of hydrophobic interactions in amyloidogenesis: example of prion-related polypeptides.
Tcherkasskaya O; Sanders W; Chynwat V; Davidson EA; Orser CS
J Biomol Struct Dyn; 2003 Dec; 21(3):353-65. PubMed ID: 14616031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
